|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/22 | |
| A61K 38/26 | |||
| A61P 9/00 |
| (11) | Patento numeris | 1888103 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06740942.5 |
| Europos patento paraiškos padavimo data | 2006-04-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-02-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-03-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2006/013949 |
| Data | 2006-04-11 |
| (87) | Numeris | WO 2006/110887 |
| Data | 2006-10-19 |
| (30) | Numeris | Data | Šalis |
| 669876 P | 2005-04-11 | US |
| (72) |
ANDERSON, Christen, US
LIU, Que, US
|
| (73) |
AMYLIN PHARMACEUTICALS, INC.,
9360 Towne Centre Drive, San Diego, CA 92121,
US
|
| (54) | USE OF GLP-1, EXENDIN AND AGONISTS THEREOF TO DELAY OR PREVENT CARDIAC REMODELING |
| USE OF GLP-1, EXENDIN AND AGONISTS THEREOF TO DELAY OR PREVENT CARDIAC REMODELING |